Your browser doesn't support javascript.
loading
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.
Tatarian, Talar; Jiang, Wei; Leiby, Benjamin E; Grigoli, Amanda; Jimbo, Masaya; Dabbish, Nooreen; Neoptolemos, John P; Greenhalf, William; Costello, Eithne; Ghaneh, Paula; Halloran, Christopher; Palmer, Daniel; Buchler, Markus; Yeo, Charles J; Winter, Jordan M; Brody, Jonathan R.
Affiliation
  • Tatarian T; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Jiang W; Department of Pathology, Anatomy, and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Leiby BE; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Grigoli A; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Jimbo M; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Dabbish N; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Neoptolemos JP; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Greenhalf W; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Costello E; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Ghaneh P; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Halloran C; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Palmer D; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Buchler M; Department of Surgery, University of Heidelberg, Heidelberg, Germany.
  • Yeo CJ; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Winter JM; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Brody JR; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
Ann Surg ; 267(2): 364-369, 2018 02.
Article in En | MEDLINE | ID: mdl-27893535
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Biomarkers, Tumor / Carcinoma, Pancreatic Ductal / Deoxycytidine / ELAV-Like Protein 1 / Fluorouracil / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Biomarkers, Tumor / Carcinoma, Pancreatic Ductal / Deoxycytidine / ELAV-Like Protein 1 / Fluorouracil / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Year: 2018 Document type: Article Affiliation country: Country of publication: